Trial
NCT02590003
Single Agent Versus Combination Chemotherapy to Treat High-risk Elderly With Non-small Cell Lung Cancer
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Yale University
Collaborators
—
Condition
Carcinoma, Non-small Cell Lung
Intervention
Carboplatin
Why stopped
Trial was stopped after non-response to treatment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-02-28